Week of February 14, 2023 | Vol. 12, Issue 6

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners

CHPA 2023

March 19-21, 2023 - Orlando, FL

DCAT Week 2023

March 20-23, 2023 - New York City, NY

CPHI-North-America-logo-web image
en_bnr_home_global01 image

CPHI North America

April 25-27, 2023 - Philadelphia, PA

INTERPHEX 2023

April 25-27, 2023 - New York City, NY

INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A TRANSACTIONS

Pharma & Biotech

5 transactions totaling $20 million


Supplies, Equipment & Services

20 transactions totaling $15 billion


Healthcare Facilities & Distributors

9 transactions totaling $84 million


Healthcare IT & Managed Care

3 transactions

PRIVATE PLACEMENTS

Pharma & Biotech

31 transactions totaling $425 million


Supplies, Equipment & Services

22 transactions totaling $1 billion


Healthcare Facilities & Distributors

4 transactions


Healthcare IT & Managed Care

14 transactions totaling $293 million

PUBLIC OFFERINGS

Pharma & Biotech

14 transactions totaling $676 million


Supplies, Equipment & Services

12 transactions totaling $1 billion


Healthcare Facilities & Distributors

1 transaction totaling $11 million


Healthcare IT & Managed Care

0 transactions

TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.






MARKET REPORTS
Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

J&J's latest data for nipocalimab in fetal disorder suggest Momenta acquisition may still pay off

Fierce Biotech - Feb 6, 2023

ValiRx Signs Lease Deal with Nottingham Laboratories

Contract Pharma - Feb 7, 2023

CRO hVIVO inks $8.2M deal to test RSV drug in human challenge trial

Fierce Biotech - Feb 8, 2023

Gerresheimer/Corning Form Joint Venture to Meet Growing Demand for Velocity Vials

Contract Pharma - Feb 9, 2023

'Expect us to act' on M&A, AbbVie CEO says as company plots post-Humira plans

Fierce Biotech - Feb 9, 2023

Takeda acquires Nimbus Therapeutics’ subsidiary

Pharmaceutical Technology - Feb 10, 2023

West Expands Corning Alliance, Launches First Product

Contract Pharma - Feb 10, 2023

Labcorp Launches Independent Clinical Development Business

Contract Pharma - Feb 13, 2023

TANNER NEWS

Linkedin  

How real-world data capture in EAPs helps regulatory approval

Real-world data capture is becoming increasingly important in pharmaceutical decision-making. Tanner EVP John Lagus describes the connection between RWD and early access programs and the role this plays in the approval of critical medicines. Read more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.